SREBP-2 is a transcription factor that regulates cholesterol synthesis by activating the expression of genes for HMG-CoA reductase and other enzymes of the cholesterol synthetic pathway. Cayman's SREBP-2 Cell-Based Translocation Assay Kit provides the tools needed to study SREBP-2 movement within whole cells. The kit contains a highly specific SREBP-2 primary antibody together with a DyLightTM (trademarked by Thermo Scientific) conjugated secondary antibody in a ready to use format. Also included as a positive control is a cholesterol trafficking inhibitor, U18666A, which has been shown to activate SREBP-2 translocation into nuclei by scientists at Cayman Chemical Company.